Frank Rimerman Advisors LLC Decreases Stake in Procter & Gamble Company (The) $PG

Frank Rimerman Advisors LLC lowered its position in shares of Procter & Gamble Company (The) (NYSE:PG) by 54.4% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,252 shares of the company’s stock after selling 13,406 shares during the quarter. Frank Rimerman Advisors LLC’s holdings in Procter & Gamble were worth $1,613,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of PG. Halbert Hargrove Global Advisors LLC bought a new stake in Procter & Gamble during the third quarter worth $25,000. Saranac Partners Ltd bought a new position in Procter & Gamble in the 3rd quarter valued at $30,000. Corundum Trust Company INC bought a new position in Procter & Gamble in the 3rd quarter valued at $32,000. Caitlin John LLC purchased a new stake in shares of Procter & Gamble during the 3rd quarter valued at $34,000. Finally, Marquette Asset Management LLC purchased a new stake in shares of Procter & Gamble during the 3rd quarter valued at $37,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Insider Transactions at Procter & Gamble

In other news, insider Moses Victor Javier Aguilar sold 15,169 shares of the stock in a transaction dated Friday, February 13th. The shares were sold at an average price of $162.28, for a total value of $2,461,625.32. Following the sale, the insider directly owned 44,735 shares of the company’s stock, valued at approximately $7,259,595.80. This represents a 25.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Chairman Jon R. Moeller sold 162,232 shares of the stock in a transaction dated Thursday, February 12th. The stock was sold at an average price of $162.45, for a total transaction of $26,354,588.40. Following the completion of the sale, the chairman directly owned 319,385 shares in the company, valued at approximately $51,884,093.25. The trade was a 33.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 348,618 shares of company stock valued at $55,462,643. 0.20% of the stock is currently owned by company insiders.

Procter & Gamble Trading Down 0.2%

Shares of Procter & Gamble stock opened at $144.19 on Thursday. The stock has a market capitalization of $335.10 billion, a P/E ratio of 21.36, a P/E/G ratio of 5.08 and a beta of 0.41. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.51 and a current ratio of 0.72. The stock’s 50-day simple moving average is $153.85 and its 200 day simple moving average is $149.84. Procter & Gamble Company has a 52-week low of $137.62 and a 52-week high of $174.80.

Procter & Gamble (NYSE:PG) last announced its quarterly earnings results on Friday, January 23rd. The company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.86 by $0.02. The company had revenue of $22.21 billion for the quarter, compared to analysts’ expectations of $22.36 billion. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. Procter & Gamble’s revenue was up 1.5% compared to the same quarter last year. During the same period in the prior year, the company posted $1.88 EPS. As a group, research analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.

Procter & Gamble Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, February 17th. Shareholders of record on Friday, January 23rd were given a dividend of $1.0568 per share. The ex-dividend date was Friday, January 23rd. This represents a $4.23 annualized dividend and a dividend yield of 2.9%. Procter & Gamble’s dividend payout ratio is currently 62.67%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Erste Group Bank downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a report on Tuesday, March 24th. UBS Group lifted their price objective on shares of Procter & Gamble from $161.00 to $170.00 and gave the stock a “buy” rating in a research report on Friday, January 23rd. Rothschild & Co Redburn boosted their target price on shares of Procter & Gamble from $155.00 to $157.00 and gave the company a “neutral” rating in a research note on Friday, January 23rd. TD Cowen reduced their target price on shares of Procter & Gamble from $156.00 to $142.00 and set a “hold” rating for the company in a research report on Wednesday. Finally, BNP Paribas Exane decreased their price target on shares of Procter & Gamble from $172.00 to $164.00 and set an “outperform” rating for the company in a research note on Friday, January 16th. Twelve analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $167.06.

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Investors are rotating into defensive, dividend-rich consumer staples as recession odds rise, which supports demand for PG stock as a low-beta hedge. As Recession Odds Climb, Defensive Sectors Continue to Outperform (PG)
• Positive Sentiment: New OLAY peptide research was presented at a dermatology conference and P&G plans to integrate proprietary peptide technologies into product formulas—an R&D catalyst that could support premium pricing and brand value over time. OLAY Peptide Research Puts New Spotlight On Procter And Gamble Valuation
• Positive Sentiment: Recent session saw PG outperform the market on a prior close, reflecting investor preference for staples amid broader weakness. This shows defensive demand can provide near-term support. Procter & Gamble (PG) Ascends While Market Falls
• Neutral Sentiment: Analysts expect P&G’s upcoming fiscal Q3 results to show low single-digit EPS growth—this raises the bar modestly: a beat could lift the stock, while a slight miss may reinforce current caution. What to Expect From Procter & Gamble’s Next Quarterly Earnings Report
• Neutral Sentiment: Market commentary and analyst notes on consumer goods (including P&G and peers) are circulating, offering mixed takes that could influence near-term analyst revisions but contain no single decisive catalyst. Analysts Offer Insights on Consumer Goods Companies: Procter & Gamble (PG) and Costco (COST)
• Negative Sentiment: TD Cowen cut its price target to $142 from $156 and kept a Hold rating, citing oil-related input-cost inflation tied to geopolitical tensions—this analyst action puts downward pressure on sentiment and could limit near-term upside. TD Cowen Adjusts Price Target on Procter & Gamble to $142 from $156; Maintains Hold Rating
• Negative Sentiment: Reports say Deutsche Bank has lowered expectations for P&G, and coverage notes broadly point to cost pressures (including oil-related input inflation from Middle East tensions) that could compress margins if raw-material costs accelerate. Deutsche Bank Aktiengesellschaft Has Lowered Expectations for Procter & Gamble (NYSE:PG) Stock Price
• Negative Sentiment: Coverage summarizing analyst downgrades highlights Iran-war related cost risks and has contributed to recent negative headlines and downgrades that weigh on sentiment. Wall Street Downgrades Procter & Gamble Amid Iran War Cost Pressures and More

Procter & Gamble Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.